| 1-8 | Acyclovir |
| 100-8 | Cefoperazone (minimum inhibitory concentration (mic)) |
| 100041-3 | Aminoglycoside |
| 100042-1 | Atovaquone |
| 100043-9 | Azithromycin+Ethambutol |
| 100044-7 | Cefcapene |
| 100045-4 | Cefozopran |
| 100046-2 | Cefquinome |
| 100047-0 | Cefteram |
| 100048-8 | Clarithromycin+Ethambutol |
| 100049-6 | Eravacycline |
| 100050-4 | Erythromycin+Ethambutol |
| 100051-2 | Ethambutol+rifAMPin |
| 100052-0 | Flomoxef |
| 100053-8 | Fluoroquinolone |
| 100054-6 | Gamithromycin |
| 100055-3 | Optochin |
| 100056-1 | Panipenem |
| 100057-9 | Prothionamide |
| 100058-7 | Prulifloxacin |
| 100059-5 | Rifapentine |
| 100060-3 | Tildipirosin |
| 100061-1 | Tosufloxacin |
| 100699-8 | Rifabutin+Ethambutol |
| 100872-1 | Bacteria producing polysaccharide from sucrose in Isolate (qualitative) |
| 100905-9 | Gram positive bacteria identified in Isolate (organism specific culture) |
| 100983-6 | HIV reverse transcriptase failed codons (genotype method) |
| 100984-4 | HIV 1 group M RNA genotype (genotype method) |
| 100985-1 | HIV protease failed codons (genotype method) |
| 100986-9 | HIV integrase failed codons (genotype method) |
| 101-6 | Cefoperazone (disk diffusion (kb)) |
| 101222-8 | Meropenem+Vaborbactam (disk diffusion (kb)) |
| 101250-9 | Aspergillus fumigatus in Isolate (qualitative) |
| 101517-1 | Canine parvovirus DNA VP2 gene in Isolate (qualitative, sequencing) |
| 101522-1 | Porcine deltacoronavirus S gene in Isolate (sequencing) |
| 101525-4 | Valnemulin (minimum inhibitory concentration (mic)) |
| 101526-2 | Tylvalosin (minimum inhibitory concentration (mic)) |
| 101527-0 | Porcine epidemic diarrhea virus S1 gene in Isolate (sequencing) |
| 101528-8 | Mycoplasma sp DNA in Isolate (sequencing) |
| 101529-6 | Mycoplasma sp DNA in Isolate (sequencing) |
| 101533-8 | Porcine reproductive and respiratory syndrome virus ORF5 gene sequence homology to RespPRRS in Isolate (sequencing) |
| 101536-1 | Salmonella sp whole genome in Isolate (sequencing) |
| 101672-4 | Carbapenemase enzyme panel - Isolate (rapid immunoassay) |
| 101673-2 | KPC carbapenemase in Isolate (qualitative, rapid immunoassay) |
| 101674-0 | OXA-48-like carbapenemase in Isolate (qualitative, rapid immunoassay) |
| 101675-7 | IMP Carbapenemase in Isolate (qualitative, rapid immunoassay) |
| 101676-5 | VIM Carbapenemase in Isolate (qualitative, rapid immunoassay) |
| 101677-3 | NDM Carbapenemase in Isolate (qualitative, rapid immunoassay) |
| 102120-3 | Carbapenemase in Isolate (immunoassay) |
| 103-2 | Ceforanide (minimum lethal concentration (mlc)) |
| 103608-6 | Sulbactam+Durlobactam (gradient strip) |
| 103673-0 | Isavuconazole in Isolate (gradient strip) |
| 103958-5 | Ofloxacin (qualitative, genotype method) |
| 103959-3 | cycloSERINE (qualitative, genotype method) |
| 103960-1 | Prothionamide (qualitative, genotype method) |
| 104-0 | Ceforanide (minimum inhibitory concentration (mic)) |
| 104447-8 | Salmonella paratyphi DNA in Isolate (qualitative, naa with probe detection) |
| 104448-6 | Salmonella paratyphi in Isolate (agglutination) |
| 104450-2 | Salmonella typhi DNA in Isolate (qualitative, naa with probe detection) |
| 104599-6 | Fungal susceptibility panel - Isolate (minimum inhibitory concentration (mic)) |
| 104691-1 | Clofazimine+Amikacin (minimum inhibitory concentration (mic)) |
| 104767-9 | Salmonella sp in Isolate (sequencing) |
| 104772-9 | Salmonella sp serotype in Isolate (sequencing) |
| 104774-5 | Salmonella sp antigenic formula in Isolate (sequencing) |
| 104864-4 | Beta lactamase.extended spectrum (qualitative) |
| 104991-5 | Bacterial resistance panel |
| 105-7 | Ceforanide (disk diffusion (kb)) |
| 105179-6 | Aztreonam+Avibactam (gradient strip) |
| 105268-7 | Clindamycin (mic.erythromycin induced resistance) |
| 105277-8 | Beta lactamase in Isolate (qualitative) |
| 105900-5 | Bacteria Identification in Isolate (qualitative) |
| 106429-4 | Botulinum neurotoxin producing species in Isolate (endopep-ms) |
| 106432-8 | cefTAZidime+cloxacillin (disk diffusion (kb)) |
| 106433-6 | cefOXitin Qualitative (qualitative) |
| 106434-4 | Aztreonam+Avibactam (minimum inhibitory concentration (mic)) |
| 106435-1 | Beta lactamase.AmpC type |
| 10653-4 | Clotrimazole (minimum inhibitory concentration (mic)) |
| 10654-2 | Clotrimazole (minimum lethal concentration (mlc)) |
| 106742-0 | Letermovir (qualitative, genotype method) |
| 106843-6 | Cefotaxime+Cloxacillin in Isolate (disk diffusion (kb)) |
| 106858-4 | Rezafungin |
| 106859-2 | Sulbactam+Durlobactam |
| 106861-8 | Cytomegalovirus UL56 gene mutations detected |
| 10697-1 | Nystatin (minimum inhibitory concentration (mic)) |
| 10698-9 | Nystatin (minimum lethal concentration (mlc)) |
| 107-3 | Cefotaxime (minimum lethal concentration (mlc)) |
| 107195-0 | Aztreonam+Avibactam (disk diffusion (kb)) |
| 10720-1 | Terbinafine (minimum inhibitory concentration (mic)) |
| 10721-9 | Terbinafine (minimum lethal concentration (mlc)) |
| 107337-8 | Amikacin liposome inhaled breakpoints (minimum inhibitory concentration (mic)) |
| 108-1 | Cefotaxime (minimum inhibitory concentration (mic)) |
| 108289-0 | Yeast susceptibility limited panel - Isolate (minimum inhibitory concentration (mic)) |
| 10868-8 | Bacitracin (disk diffusion (kb)) |
| 109-9 | Cefotaxime (disk diffusion (kb)) |
| 11-7 | Amikacin (minimum lethal concentration (mlc)) |
| 111-5 | cefoTEtan (minimum lethal concentration (mlc)) |
| 111516-1 | Ciclopirox in Isolate (minimum inhibitory concentration (mic)) |
| 112-3 | cefoTEtan (minimum inhibitory concentration (mic)) |
| 113-1 | cefoTEtan (disk diffusion (kb)) |
| 115-6 | cefOXitin (minimum lethal concentration (mlc)) |